(Q28508726)

24 January 2017

title

Muscle-specific Pparg deletion causes insulin resistance (English)

1 reference

B cell leukemia/lymphoma 2 related protein A1a

24 January 2017

main subject

1 reference

GOA release 2020-03-11

1 reference

1 reference

Ronald M. Evans

0 references

Jerrold M. Olefsky

object named as

Jerrold Olefsky

1 reference

24 January 2017

Andrea L. Hevener

1 reference

24 January 2017

Weimin He

1 reference

24 January 2017

Yaacov Barak

1 reference

24 January 2017

Jamie Le

1 reference

24 January 2017

Gautam Bandyopadhyay

1 reference

24 January 2017

Peter Olson

1 reference

24 January 2017

Jason Wilkes

1 reference

24 January 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

24 January 2017

1 reference

24 January 2017

1 reference

24 January 2017

1 reference

24 January 2017

page(s)

1491–1497

1 reference

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

24 January 2017

cites work

1 reference

7 January 2021

Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease

1 reference

7 January 2021

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

7 January 2021

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

7 January 2021

In vitro studies on the action of CS-045, a new antidiabetic agent

1 reference

7 January 2021

Regulation of glucose transport by pioglitazone in cultured muscle cells

1 reference

7 January 2021

The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats.

1 reference

7 January 2021

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

1 reference

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

7 January 2021

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

7 January 2021

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

7 January 2021

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

1 reference

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

7 January 2021

The RXR heterodimers and orphan receptors

1 reference

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

7 January 2021

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

1 reference

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

7 January 2021

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

1 reference

7 January 2021

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

7 January 2021

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner

1 reference

7 January 2021

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

1 reference

7 January 2021

Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma

1 reference

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

7 January 2021

Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.

1 reference

7 January 2021

PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes

1 reference

7 January 2021

Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action

1 reference

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

7 January 2021

A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance

1 reference

7 January 2021

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

1 reference

7 January 2021

c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade

1 reference

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

7 January 2021

Obesity and insulin resistance

1 reference

7 January 2021

Pathogenesis of NIDDM. A balanced overview

1 reference

7 January 2021

Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.

1 reference

7 January 2021

Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells

1 reference

7 January 2021

Reduced insulin-stimulated glucose transport in denervated muscle is associated with impaired Akt-alpha activation.

1 reference

7 January 2021

Influence of hyperglycemia on insulin's in vivo effects in type II diabetes

1 reference

7 January 2021

Influences of glucose loading and of injected insulin on hepatic glucose output

1 reference

7 January 2021